Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Chlorinated and brominated bisphenol A derivatives: Synthesis, characterization and determination in water samples.

Doumas M, Rouillon S, Venisse N, Nadeau C, Pierre Eugene P, Farce A, Chavatte P, Dupuis A, Migeot V, Carato P.

Chemosphere. 2018 Dec;213:434-442. doi: 10.1016/j.chemosphere.2018.09.061. Epub 2018 Sep 12.

PMID:
30243209
2.

Toward the Discovery of a Novel Class of YAP⁻TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP⁻TEAD Protein⁻Protein Interface.

Gibault F, Coevoet M, Sturbaut M, Farce A, Renault N, Allemand F, Guichou JF, Drucbert AS, Foulon C, Magnez R, Thuru X, Corvaisier M, Huet G, Chavatte P, Melnyk P, Bailly F, Cotelle P.

Cancers (Basel). 2018 May 8;10(5). pii: E140. doi: 10.3390/cancers10050140.

3.

Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping.

Tuo W, Bollier M, Leleu-Chavain N, Lemaire L, Barczyk A, Dezitter X, Klupsch F, Szczepanski F, Spencer J, Chavatte P, Millet R.

Eur J Med Chem. 2018 Feb 25;146:68-78. doi: 10.1016/j.ejmech.2018.01.034. Epub 2018 Jan 16.

PMID:
29360044
4.

Importance of the second extracellular loop for melatonin MT1 receptor function and absence of melatonin binding in GPR50.

Clement N, Renault N, Guillaume JL, Cecon E, Journé AS, Laurent X, Tadagaki K, Cogé F, Gohier A, Delagrange P, Chavatte P, Jockers R.

Br J Pharmacol. 2018 Aug;175(16):3281-3297. doi: 10.1111/bph.14029. Epub 2017 Oct 27.

PMID:
28898928
5.

Development and validation of a reversed-phase HPLC method for the quantification of paclitaxel in different PLGA nanocarriers.

Furman C, Carpentier R, Barczyk A, Chavatte P, Betbeder D, Lipka E.

Electrophoresis. 2017 Oct;38(19):2536-2541. doi: 10.1002/elps.201600552. Epub 2017 Apr 28.

PMID:
28370074
6.

Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.

Tuo W, Leleu-Chavain N, Spencer J, Sansook S, Millet R, Chavatte P.

J Med Chem. 2017 Jan 12;60(1):4-46. doi: 10.1021/acs.jmedchem.6b00538. Epub 2016 Nov 14. Review.

PMID:
27766867
7.

Exploring chiral separation of 3-carboxamido-5-aryl isoxazole derivatives by supercritical fluid chromatography on amylose and cellulose tris dimethyl- and chloromethyl phenylcarbamate polysaccharide based stationary phases.

Zehani Y, Lemaire L, Ghinet A, Millet R, Chavatte P, Vaccher C, Lipka E.

J Chromatogr A. 2016 Oct 7;1467:473-481. doi: 10.1016/j.chroma.2016.07.041. Epub 2016 Jul 17.

PMID:
27452989
8.

Design, synthesis and biological evaluation of potent FAAH inhibitors.

Tuo W, Leleu-Chavain N, Barczyk A, Renault N, Lemaire L, Chavatte P, Millet R.

Bioorg Med Chem Lett. 2016 Jun 1;26(11):2701-5. doi: 10.1016/j.bmcl.2016.04.004. Epub 2016 Apr 23.

PMID:
27117424
9.

Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolines.

Moas-Héloire V, Renault N, Batalha V, Arias AR, Marchivie M, Yous S, Deguine N, Buée L, Chavatte P, Blum D, Lopes L, Melnyk P, Agouridas L.

Eur J Med Chem. 2015 Dec 1;106:15-25. doi: 10.1016/j.ejmech.2015.10.030. Epub 2015 Oct 19.

10.

Docking study: PPARs interaction with the selected alternative plasticizers to di(2-ethylhexyl) phthalate.

Kambia N, Farce A, Belarbi K, Gressier B, Luyckx M, Chavatte P, Dine T.

J Enzyme Inhib Med Chem. 2016;31(3):448-55. doi: 10.3109/14756366.2015.1037748. Epub 2015 May 5.

PMID:
25942360
11.

Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis.

El Bakali J, Muccioli GG, Body-Malapel M, Djouina M, Klupsch F, Ghinet A, Barczyk A, Renault N, Chavatte P, Desreumaux P, Lambert DM, Millet R.

ACS Med Chem Lett. 2014 Dec 4;6(2):198-203. doi: 10.1021/ml500439x. eCollection 2015 Feb 12.

12.

Relationships between Th1 or Th2 iNKT cell activity and structures of CD1d-antigen complexes: meta-analysis of CD1d-glycolipids dynamics simulations.

Laurent X, Renault N, Farce A, Chavatte P, Hénon E.

PLoS Comput Biol. 2014 Nov 6;10(11):e1003902. doi: 10.1371/journal.pcbi.1003902. eCollection 2014 Nov.

13.

Enantioseparation of pyroglutamide derivatives on polysaccharide based chiral stationary phases by high-performance liquid chromatography and supercritical fluid chromatography: a comparative study.

Baudelet D, Schifano-Faux N, Ghinet A, Dezitter X, Barbotin F, Gautret P, Rigo B, Chavatte P, Millet R, Furman C, Vaccher C, Lipka E.

J Chromatogr A. 2014 Oct 10;1363:257-69. doi: 10.1016/j.chroma.2014.06.090. Epub 2014 Jul 4.

PMID:
25039068
14.

Therapeutical potential of CB₂ receptors in immune-related diseases.

Leleu-Chavain N, Desreumaux P, Chavatte P, Millet R.

Curr Mol Pharmacol. 2013 Nov;6(3):183-203. Review.

PMID:
24720538
15.

Switching cannabinoid response from CB(2) agonists to FAAH inhibitors.

Tourteau A, Leleu-Chavain N, Body-Malapel M, Andrzejak V, Barczyk A, Djouina M, Rigo B, Desreumaux P, Chavatte P, Millet R.

Bioorg Med Chem Lett. 2014 Mar 1;24(5):1322-6. doi: 10.1016/j.bmcl.2014.01.056. Epub 2014 Jan 28.

PMID:
24508127
16.

Switching invariant natural killer T (iNKT) cell response from anticancerous to anti-inflammatory effect: molecular bases.

Laurent X, Bertin B, Renault N, Farce A, Speca S, Milhomme O, Millet R, Desreumaux P, Hénon E, Chavatte P.

J Med Chem. 2014 Jul 10;57(13):5489-508. doi: 10.1021/jm4010863. Epub 2014 Feb 12. Review.

PMID:
24428717
17.

Preclinical studies of a specific PPARγ modulator in the control of skin inflammation.

Mastrofrancesco A, Kovacs D, Sarra M, Bastonini E, Cardinali G, Aspite N, Camera E, Chavatte P, Desreumaux P, Monteleone G, Picardo M.

J Invest Dermatol. 2014 Apr;134(4):1001-1011. doi: 10.1038/jid.2013.448. Epub 2013 Oct 28.

18.

3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis.

Tourteau A, Andrzejak V, Body-Malapel M, Lemaire L, Lemoine A, Mansouri R, Djouina M, Renault N, El Bakali J, Desreumaux P, Muccioli GG, Lambert DM, Chavatte P, Rigo B, Leleu-Chavain N, Millet R.

Bioorg Med Chem. 2013 Sep 1;21(17):5383-94. doi: 10.1016/j.bmc.2013.06.010. Epub 2013 Jun 15.

PMID:
23849204
19.

[From cannabis to selective CB2R agonists: molecules with numerous therapeutical virtues].

Leleu-Chavain N, Biot C, Chavatte P, Millet R.

Med Sci (Paris). 2013 May;29(5):523-8. doi: 10.1051/medsci/2013295016. Epub 2013 May 28. French.

20.

Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR features.

Renault N, Laurent X, Farce A, El Bakali J, Mansouri R, Gervois P, Millet R, Desreumaux P, Furman C, Chavatte P.

Chem Biol Drug Des. 2013 Apr;81(4):442-54. doi: 10.1111/cbdd.12095.

PMID:
23217060

Supplemental Content

Loading ...
Support Center